Intranasal Vaccination With Recombinant Human Adenovirus Encoding trans -Sialidase Gene Protects Mice From Lethal Subcutaneous and Oral Trypanosoma cruzi Challenges
The Journal of Infectious Diseases · 2026
DOI: 10.1093/infdis/jiag227 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Isaú Henrique Noronha und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology and Parasitology, Federal University of São Paulo, São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Neuraminidase, Chagas Disease, Protozoan Vaccines, Trypanosoma cruzi. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Background
The majority of new cases of Chagas disease, caused by Trypanosoma cruzi, have been associated with oral infection. Thus, it is reasonable that any vaccine formulation developed should elicit systemic and mucosal immunity.
Methods
Antigen-specific T-cell, B-cell, antibody-secreting cell, IgG, IgA, cytokine, and parasite DNA were assessed in Balb/c mice immunized with a recombinant adenovirus replication-deficient vector encoding the parasitic trans-sialidase (rAdTS) and challenged with T. cruzi trypomastigotes.
Results
A 2-dose intranasal (IN) rAdTS administration protected mice from lethal subcutaneous and oral parasitic challenges, displaying lower parasitemia and higher survival than control mice. Although intramuscular (IM) rAdTS immunization seemed more immunogenic for CD4+ and CD8+ T cells, IN vaccinees presented the highest responses after parasite exposure. Oral parasitic challenge triggered differential cytokine and cytotoxic transcriptome profiles in the hearts of IM and IN vaccinees. IM and IN rAdTS vaccinations induced high TS-specific IgG and subclass titers in the serum, with predominance of IgG-secreting cells in the spleen and draining lymph nodes. Only IN vaccinees produced TS-specific IgA in mucosal tissues and serum, which showed inverse correlation with parasitemia in vivo. Serum samples from the IN rAdTS vaccinees significantly inhibited parasite invasion in vitro relative to IM counterparts. In addition, IN vaccinees had very low levels of parasite DNA in parasite-reservoir tissues upon oral parasitic challenge relative to IM counterparts.
Conclusions
IN rAdTS vaccination can effectively protect mice against acute Chagas disease caused by lethal distinct T. cruzi challenges, providing an interesting alternative for future vaccine clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Immunology and Parasitology, Federal University of São Paulo, São Paulo, São Paulo, Brazil.
- Department of Biosciences, Federal University of São Paulo, Santos, São Paulo, Brazil.
- School of Pharmaceutical Sciences, São Paulo State University, Araraquara, São Paulo, Brazil.
- Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
- Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.
- Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
ORCID-Profile: Isaú Henrique Noronha, Liana Nanako Wada, Jociel Klleyton Santos Santana, Rafael Domingos do Valle, João Aristeu da Rosa, Daniela Santoro Rosa, Young Kim, Marcela F Lopes, Daniel Araki Ribeiro, Karina R Bortoluci, Gustavo H G Trossini, Eduardo L V Silveira, José Ronnie C de Vasconcelos
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Noronha, I. H., Wada, L. N., Rossetto, B. S., Moraschi, B. F., Ferreira, C. P., Santos Santana, J. K., do Valle, R. D., Júnior, L. C. G. P., Aristeu da Rosa, J., Rosa, D. S., Kim, Y., Lopes, M. F., Ribeiro, D. A., Gazzinelli, R. T., Bortoluci, K. R., Trossini, G. H. G., Silveira, E. L. V., & de Vasconcelos, J. R. C. (2026). Intranasal Vaccination With Recombinant Human Adenovirus Encoding trans -Sialidase Gene Protects Mice From Lethal Subcutaneous and Oral Trypanosoma cruzi Challenges. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiag227
Vancouver
Noronha IH, Wada LN, Rossetto BS, Moraschi BF, Ferreira CP, Santos Santana JK, et al. Intranasal Vaccination With Recombinant Human Adenovirus Encoding trans -Sialidase Gene Protects Mice From Lethal Subcutaneous and Oral Trypanosoma cruzi Challenges. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiag227
BibTeX
@article{Noronha2026,
author = {Noronha, Isaú Henrique and Wada, Liana Nanako and Rossetto, Barbara Santos and Moraschi, Barbara F and Ferreira, Camila P and Santos Santana, Jociel Klleyton and do Valle, Rafael Domingos and Júnior, Luiz Carlos Gonçalo Piza and Aristeu da Rosa, João and Rosa, Daniela Santoro and Kim, Young and Lopes, Marcela F and Ribeiro, Daniel Araki and Gazzinelli, Ricardo T and Bortoluci, Karina R and Trossini, Gustavo H G and Silveira, Eduardo L V and de Vasconcelos, José Ronnie C},
title = {Intranasal Vaccination With Recombinant Human Adenovirus Encoding trans -Sialidase Gene Protects Mice From Lethal Subcutaneous and Oral Trypanosoma cruzi Challenges},
journal = {The Journal of Infectious Diseases},
year = {2026},
doi = {10.1093/infdis/jiag227}
}
EUVIMED